During the past decade, Northumbria Healthcare NHS Foundation Trust conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 3 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northumbria Healthcare NHS Foundation Trust" #1 sponsor was "Smith & Nephew, Inc." with 4 trials, followed by "Northumbria Healthcare NHS Foundation Trust" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "University of Nottingham" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northumbria Healthcare NHS Foundation Trust" #1 collaborator was "ARC Medical Design Ltd" with 1 trials as a collaborator, "Aalborg University" with 1 trials as a collaborator, "Alfried Krupp Krankenhaus" with 1 trials as a collaborator, "Azienda Ospedaliera di Perugia" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Northumbria Healthcare NHS Foundation Trust" are "Rheumatoid Arthritis" (4 trials), "Osteoarthritis" (2 trials), "Pressure Ulcer" (2 trials), "Wounds and Injuries" (2 trials) and "Adenoma" (1 trials). Many other conditions were trialed in "Northumbria Healthcare NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Northumbria Healthcare NHS Foundation Trust" are "Drug" (9 trials), "Other" (7 trials), "Device" (6 trials), "Procedure" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (2 trials), "Placebo" (2 trials), "ACTICOAT" (1 trials), "Actico, short-stretch, inelastic dressing" (1 trials) and "Apixaban Oral Tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northumbria Healthcare NHS Foundation Trust" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Northumbria Healthcare NHS Foundation Trust". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Northumbria Healthcare NHS Foundation Trust, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Northumbria Healthcare NHS Foundation Trust, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 12 trials that are defined as “Not Applicable".